What is the Gleason Score?

The most common system to evaluate and describe prostate cancer currently in use is the Gleason grading system. After a biopsy, the pathologist assigns a primary grade from 1 to 5, with 5 being the...

What is new in prostate cancer research and development?

Key research areas in relation to Prostate Cancer are discussed below.  Brief descriptions are supported by hyperlinks to the most relevant research papers and current affairs news reports and...

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previo...

BRIEF-S&P 500 to add Regeneron, drop MetroPCS

April 24 (Reuters) - * S&P says to add Regeneron Pharmaceuticals Inc to S&P 500 * S&P says Regeneron to replace MetroPCS Communications Inc which is

Sanofi acquires undisclosed common stock from Regeneron Pharmaceuticals

Sanofi intends to acquire Common Stock of Regeneron through open market purchases and direct purchases from shareholders. As a result, Sanofi intends that the value of its ownership of voting securiti...

Regeneron: Solid Q1 Creates Platform For Further Upside

ByPropThink: By Ivan Deryugin Since our original report on Regeneron Pharmaceuticals (REGN) in mid-December, shares of the company have rallied over 47%, vs. a rise of over 27% for the Nasdaq Biotec...

Why Regeneron May Not Profit Much From Today’s FDA Approval

The Food and Drug Administration just announced that it approved Zaltrap for colorectal cancer, giving Tarrytown, N.Y.-based Regeneron its third approved drug — an impressive achievement. . Rege...

Regeneron says Sanofi plans to buy shares

Feb 11 (Reuters) - Regeneron Pharmaceuticals Inc on Monday said it has received notice that Sanofi SA intends to acquire Regeneron's common stock through open market purchases and direct purchases fr...

CORRECTED-Regeneron says Sanofi plans to buy shares

Feb 11 (Reuters) - Regeneron Pharmaceuticals Inc on Monday said it has received notice that Sanofi SA intends to acquire Regeneron's common stock through open market purchases and direct purchases fr...

Sanofi acquisition of Regeneron a possibility?

Acquisition possibility? Sanofi and Regeneron are already partners with CEO Chris Viehbachers intent on new deals. It started with Sanofi, a top pharma company based in France, purchasing enough Regen...

Aflibercept.

In November 2011, aflibercept (Eylea; Regeneron Pharmaceuticals), a recombinant fusion protein that binds to members of the vascular endothelial growth factor family, was approved by the US Food and D...

Factors associated with the timing of introduction of complementary feeding: the Generation R Study.

Background/objectives:Many parents do not follow recommendations for the timing of introduction of complementary feeding. The aim of this study was to identify determinants associated with the timing...

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.

Pharmacological inhibition of VEGF-A has proven to be effective in inhibiting angiogenesis and vascular leak associated with cancers and various eye diseases. However, little information is currently...

Simultaneous introduction of a novel high fat diet and wheel running induces anorexia.

Voluntary wheel running (WR) is a form of physical activity in rodents that influences ingestive behavior. The present report describes an anorexic behavior triggered by the simultaneous introduction...

Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting.

Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to con...